The growing prevalence of cancer and infectious diseases is fueling the demand for customized peptide synthesis across the world. According to the World Health Organization (WHO), cancer claimed the lives of 9.6 million people all over the world in 2018. Furthermore, the emergence of various new peptide-based products is also propelling the advancement of the customized peptide synthesis market. For example, Biotage AB introduced its new Alstra remote software in September 2018, which assists users in programing the peptide synthesis setup offline, importing peptide synthesis, and executing the synthesis on Initiator + Alstra.
Additionally, several research institutes are actively focusing on conducting advanced research activities pertaining to peptide synthesis. For instance, researchers working at the Massachusetts Institute of Technology (MIT) developed a machine that can develop large volumes of customized peptides quickly. Moreover, the machine can create links between amino acids in nearly 37 seconds and produce peptide molecules (consisting of up to 60 amino acids) in less than an hour. Thus, the research and development (R&D) activities being conducted in peptide synthesis are driving the expansion of the industry.
Customized peptide synthesis finds applications in academic research institutes and organizations operating in the commercial sector. Between these, the requirement for customized peptide synthesis is expected to surge in the commercial sector in the coming years. This is credited to the rapid advancements being made in the chemical peptide synthesis process and the rise in the commercial potential of customized peptides, owing to the adoption of various modified amino acids
Thus, the demand for customized peptide synthesis will soar all over the world in the upcoming years, mainly because of the rising incidence of cancer and infectious diseases and increasing R&D activities in the domain of peptide synthesis.
Browse Full Report Customized Peptide Synthesis Market Share Analysis